Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajnikant Sharma

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Clinical Pharmacology and Therapeutics|February 6, 2021
Evaluation Strategies for Triple-Drug Combinations against Carbapenemase-Producing Klebsiella Pneumoniae in an In Vitro Hollow-Fiber Infection ModelEstefany Garcia, John K Diep, Rajnikant Sharma, et al.
International Journal of Antimicrobial Agents|March 15, 2022
Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniaeRajnikant Sharma, Estefany Garcia, John K Diep, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2023
Proof-of-concept for incorporating mechanistic insights from multi-omics analyses of polymyxin B in combination with chloramphenicol against Klebsiella pneumoniaePatrick O Hanafin, Nusaibah Abdul Rahim, Rajnikant Sharma, et al.
Computational and Structural Biotechnology Journal|March 14, 2022
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant <i>Klebsiella pneumoniae</i>Maytham Hussein, Labell J M Wong, Jinxin Zhao, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
<i>In Vitro</i> Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeDennis Huang, Brenda Yu, John K Diep, et al.
International Journal of Antimicrobial Agents|February 22, 2026
A window into resistance: the MEGA-plate as a model of evolutionary dynamicsMaytham Hussein, Rafah Allobawi, James Barclay, et al.
Msystems|December 11, 2023
High-level nitrofurantoin resistance in a clinical isolate of <i>Klebsiella pneumoniae:</i> a comparative genomics and metabolomics analysisMaytham Hussein, Zetao Sun, Jane Hawkey, et al.
Infectious Diseases and Therapy|September 3, 2025
A Comparative Review of the Pharmacology of Dalbavancin and Oritavancin for Gram-Positive Infections: Birds of a Feather or Apples and Oranges?Maytham Hussein, James Barclay, Mark Baker, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2025
A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant <i>Klebsiella pneumoniae</i> isolates with diverse phenotypic and genotypic resistance mechanismsRamya Mahadevan, Estefany Garcia, Rajnikant Sharma, et al.
The Journal of Infectious Diseases|November 12, 2025
Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam against Metallo-β-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-Based ModelBhavatharini Arun, Eloise Liu, Quentin Vallé, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|February 6, 2021
Evaluation Strategies for Triple-Drug Combinations against Carbapenemase-Producing Klebsiella Pneumoniae in an In Vitro Hollow-Fiber Infection ModelEstefany Garcia, John K Diep, Rajnikant Sharma, et al.
International Journal of Antimicrobial Agents|March 15, 2022
Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniaeRajnikant Sharma, Estefany Garcia, John K Diep, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2023
Proof-of-concept for incorporating mechanistic insights from multi-omics analyses of polymyxin B in combination with chloramphenicol against Klebsiella pneumoniaePatrick O Hanafin, Nusaibah Abdul Rahim, Rajnikant Sharma, et al.
Computational and Structural Biotechnology Journal|March 14, 2022
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant <i>Klebsiella pneumoniae</i>Maytham Hussein, Labell J M Wong, Jinxin Zhao, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
<i>In Vitro</i> Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeDennis Huang, Brenda Yu, John K Diep, et al.
International Journal of Antimicrobial Agents|February 22, 2026
A window into resistance: the MEGA-plate as a model of evolutionary dynamicsMaytham Hussein, Rafah Allobawi, James Barclay, et al.
Msystems|December 11, 2023
High-level nitrofurantoin resistance in a clinical isolate of <i>Klebsiella pneumoniae:</i> a comparative genomics and metabolomics analysisMaytham Hussein, Zetao Sun, Jane Hawkey, et al.
Infectious Diseases and Therapy|September 3, 2025
A Comparative Review of the Pharmacology of Dalbavancin and Oritavancin for Gram-Positive Infections: Birds of a Feather or Apples and Oranges?Maytham Hussein, James Barclay, Mark Baker, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2025
A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant <i>Klebsiella pneumoniae</i> isolates with diverse phenotypic and genotypic resistance mechanismsRamya Mahadevan, Estefany Garcia, Rajnikant Sharma, et al.
The Journal of Infectious Diseases|November 12, 2025
Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam against Metallo-β-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-Based ModelBhavatharini Arun, Eloise Liu, Quentin Vallé, et al.
Pageof 4